WO2019093545A1 - Phenanthroline compound and organic light emitting device comprising same - Google Patents

Phenanthroline compound and organic light emitting device comprising same Download PDF

Info

Publication number
WO2019093545A1
WO2019093545A1 PCT/KR2017/012707 KR2017012707W WO2019093545A1 WO 2019093545 A1 WO2019093545 A1 WO 2019093545A1 KR 2017012707 W KR2017012707 W KR 2017012707W WO 2019093545 A1 WO2019093545 A1 WO 2019093545A1
Authority
WO
WIPO (PCT)
Prior art keywords
light emitting
layer
emitting portion
electrode
organic
Prior art date
Application number
PCT/KR2017/012707
Other languages
French (fr)
Korean (ko)
Inventor
이상진
김대환
정은빈
박도우
백승지
이병윤
한상미
조은상
조혜진
Original Assignee
주식회사 진웅산업
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 진웅산업 filed Critical 주식회사 진웅산업
Publication of WO2019093545A1 publication Critical patent/WO2019093545A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • H10K50/125OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light
    • H10K50/13OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light comprising stacked EL layers within one EL unit
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K99/00Subject matter not provided for in other groups of this subclass

Definitions

  • the present invention relates to a phenanthroline compound and an organic light emitting device comprising the same.
  • the organic light emitting device includes a structure in which an organic layer capable of emitting light is formed between an anode and a cathode, for converting electric energy into light energy using an organic material.
  • Organic light emitting devices can be formed in various structures, and a tandem type organic light emitting device in which a plurality of light emitting units are stacked has been studied.
  • tandem type organic light emitting device a plurality of light emitting portions including a light emitting layer are stacked between the anode and the cathode. Between the adjacent light emitting portions, a charge generating layer for generating and moving charges is located.
  • the charge generating layer requires a low driving voltage and high efficiency.
  • the present invention provides a novel phenanthroline derivative which is superior in luminous efficiency and thermal stability to a conventional material, and that the phenanthroline derivative is included in the organic layer to lower the driving voltage of the device, And to provide a light emitting element.
  • the object of the present invention is achieved by a phenanthroline compound represented by the following general formula (1).
  • R 1 is a substituted or unsubstituted aryl group having 3 to 60 carbon atoms, a substituted or unsubstituted 5 to 60 membered heteroaryl group containing at least one hetero atom selected from nitrogen, oxygen and sulfur, an arylamine group and 2 / RTI > amine group.
  • the organic light emitting device includes a first electrode, a second electrode, and at least one organic layer positioned between the first electrode and the second electrode, wherein at least one of the organic layers includes the phenanthroline compound according to the present invention. .
  • the organic material layer may include at least one layer selected from the group consisting of a light emitting layer, a hole injecting layer, a hole transporting layer, and a layer simultaneously injecting holes and transporting holes.
  • the organic material layer may include at least one layer selected from the group consisting of a light emitting layer, an electron injecting layer, an electron transporting layer, and layers simultaneously performing electron injection and electron transport.
  • the organic layer may include at least one charge generation layer (CGL).
  • CGL charge generation layer
  • the charge generation layer may be n-type.
  • an object of the present invention is to provide a plasma display panel comprising a first electrode; A second electrode; And a first light emitting unit disposed between the first electrode and the second electrode and including a first light emitting layer; A second light emitting portion located between the second electrode and the first light emitting portion and including a second light emitting layer; Wherein at least one layer of the first light emitting portion, the second light emitting portion, and the first charge generating layer includes a first charge generating layer disposed between the first light emitting portion and the second light emitting portion, Can be achieved by an organic light emitting device comprising the phenanthroline compound according to claim 2.
  • the phenanthroline derivative according to the present invention may be included in an organic layer, preferably a charge generation layer, of an organic electroluminescent device, thereby lowering the driving voltage of the device and improving the luminous efficiency. Further, the lifetime of the organic electroluminescent device can be improved by the thermal stability of the phenanthroline derivative of the present invention.
  • FIG. 1 is a cross-sectional view of an organic light emitting diode according to an embodiment of the present invention.
  • the phenanthroline compound according to the present invention is represented by the formula (1).
  • R 1 is a substituted or unsubstituted aryl group having 3 to 60 carbon atoms, a substituted or unsubstituted 5 to 60 membered heteroaryl group containing at least one hetero atom selected from nitrogen, oxygen and sulfur, an arylamine group and 2 / RTI > amine group.
  • the compound represented by the formula (1) may be selected from the group consisting of the compounds shown below.
  • the phenanthroline core in the above formula (1) contains two nitrogen atoms and introduces an aromatic compound (Aromatic Compound) at the position 2 or 8 to enrich the electrons of the nitrogen atom, The electron transfer is facilitated by the mobility.
  • nitrogen of the sp2 hybrid orbital is included in the N-type charge generation layer (N-CGL), and this nitrogen bonds with an alkali metal or an alkaline earth metal which is a dopant of the N-type charge generation layer to form a gap state . Therefore, electrons can be smoothly transferred from the P-type charge generation layer (P-CGL) to the N-type charge generation layer (N-CGL) by the gap state.
  • the hole injection layer material and the hole transport layer material used in the production of an organic light emitting device have energy levels enough to transfer holes along HOMO (highest occupied molecular orbital), and the lowest unoccupied molecular orbital (LUMO) A compound capable of having an energy level enough to block the electrons passing through the electron transporting layer.
  • HOMO highest occupied molecular orbital
  • LUMO lowest unoccupied molecular orbital
  • the core structure of the present compound exhibits stable characteristics in terms of electrons, which can contribute to improvement of lifetime of the device.
  • the derivatives prepared by introducing the substituents to be used for the light emitting layer and the electron transporting layer material can be manufactured to have appropriate energy band gaps for various arylamine type dopants, aryl type dopants, metal containing dopants and the like.
  • the compounds represented by Formula 1 have high glass transition temperature (Tg) and thus are excellent in thermal stability. This increase in thermal stability is an important factor in providing drive stability to the device.
  • the organic light emitting diode 1 is a cross-sectional view of an organic light emitting diode according to an embodiment of the present invention.
  • the organic light emitting diode 1 includes a first electrode (anode) 110, a second electrode (cathode) 120, a first light emitting portion 210, a second light emitting portion 220, A third light emitting portion 230, a first charge generating layer 240, and a second charge generating layer 250.
  • the first charge generating layer 240 and the second charge generating layer 250 may include a first electrode 110 as an organic material layer and a second charge generating layer 250.
  • the first light emitting portion 210 includes a hole injection layer 211, a first hole transporting layer 212, a first light emitting layer 213 and a first electron transporting layer 214, The second light emitting layer 222 and the second electron transporting layer 223.
  • the third light emitting portion 230 includes the third hole transporting layer 231, the third light emitting layer 232, the third hole transporting layer 231, An electron transport layer 233, and an electron injection layer 234.
  • the first charge generating layer 240 is composed of an n-type charge generating layer 241 and a p-type charge generating layer 242.
  • the second charge generating layer 250 is composed of an n-type charge generating layer 251 and a p- And a charge generation layer 252.
  • the n-type charge generation layers 241 and 251 may be doped with an alkali metal.
  • the phenanthroline compound according to the present invention may be used in combination with a first electron transport layer 214, a second electron transport layer 223, a third electron transport layer 233, an electron injection layer 234, a first charge generation layer 240 and / Or the second charge generating layer 250, and can be used for the n-type charge generating layers 241 and 251 in particular.
  • the organic light emitting element 1 described above can be variously modified. Some organic layers may be omitted or added, may not be tandem-shaped, and may be in a tandem form having two or four or more light-emitting layers.
  • the organic light emitting device 1 may include an organic layer including a layer simultaneously performing electron transport and electron injection, and in this case, the phenanthroline compound according to the present invention may also be used.
  • intermediate A 10 g, 26 mmole
  • quinoline-3-ylboronic acid 5.5 g, 31.9 mmole
  • tetrakis (triphenylphosphine) palladium (0) 11 g, 79.9 mmol
  • toluene 100 ml
  • ethanol 50 ml
  • water 50 ml
  • the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 .
  • Column purification was carried out with methylene chloride and the solvent was removed to give Intermediate C (yield 88%).
  • intermediate F 10 g, 22.6 mmol
  • bis (pinacolato) diboron 7.5 g, 29.3 mmol
  • talladium acetate 253 mg, 5%
  • SPhos 930 mg
  • Potassium 14 g, 67.8 mmol
  • dioxane 50 ml
  • the crude product is obtained by using MeOH, H 2 O and acetone as the reaction mixture.
  • the crude product was dissolved in MC by heating.
  • the silica gel was purified by silica gel, and the solvent was removed. MeOH was used to obtain Intermediate G (yield: 83%).
  • intermediate A 9 g, 25 mmole
  • 2- (4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene- 10 g, 30.3 mmol
  • tetrakis (triphenylphosphine) palladium (0) 0.9 g, 3%
  • potassium carbonate 10.5 g, 75.3 mmol
  • toluene 100 ml, ethanol 50 ml, 50 ml of water was added and the mixture was refluxed for 12 hours.
  • the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 .
  • Column purification was carried out with methylene chloride and the solvent was removed to give Intermediate H (94% yield).
  • intermediate A 15 g, 40 mmole
  • potassium carbonate (16.6 g, 120 mmol
  • toluene 150 ml
  • ethanol 75 ml
  • water 75 ml
  • the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 .
  • Column purification was carried out with hexane: ethyl acetate (10: 1) and the solvent was removed to give Intermediate I (92% yield).
  • the N-CGL characteristics can be confirmed by doping the second electron transporting layer with an alkali metal such as Li in the organic light emitting device.
  • the ITO substrate was patterned to have a light emitting area of 2 mm x 2 mm, and then washed with isopropyl alcohol and UV ozone, respectively. Thereafter, the ITO substrate was mounted on a substrate holder of a vacuum deposition apparatus, and the pressure was adjusted so that the degree of vacuum was 1 x 10 < -7 > torr.
  • HAT-CN compound was vacuum deposited to form a 5 nm thick layer. This compound served as a first hole injection layer, and NPB material was formed thereon as a first hole transport layer to a thickness of 35 nm.
  • the CPB material was hosted and the Ir compound was co-deposited to a thickness of 30 nm so as to have a mass ratio of about 10% with a dopant to form a yellow first light emitting layer.
  • a TmPyPB compound was formed on the light emitting layer to a thickness of 25 nm to form a first electron transport layer. Then, an N-type charge generation layer was formed by co-depositing a Li material to a BPhen material to a thickness of 10 nm to a mass ratio of 2%. Then, a HAT-CN compound was vacuum deposited as a P-type charge generation layer to a thickness of 5 nm. This material also serves as a second hole injection layer. On this layer, NPB material was formed to a thickness of 35 nm as a second hole transporting layer.
  • a second yellow light emitting layer was formed by co-depositing a CPB material as a host and a 30 nm thick Ir compound as a dopant in a thickness of about 10% to form a second electron transporting layer having a thickness of 25 nm.
  • a LiF material was vacuum deposited as an electron injection layer to a thickness of 1 nm.
  • Al was deposited to a thickness of 100 nm to form a cathode, thereby fabricating an organic EL device.

Abstract

The present invention relates to: a phenanthroline compound; and an organic electroluminescent device, which exhibits an excellent efficiency characteristic since one or more organic layers comprise the phenanthroline compound.

Description

페난트롤린 화합물 및 이를 포함하는 유기발광소자Phenanthroline compounds and organic light emitting devices containing them
본 발명은 페난트롤린 화합물 및 이를 포함하는 유기발광소자에 관한 것이다.The present invention relates to a phenanthroline compound and an organic light emitting device comprising the same.
유기발광소자는 유기 물질을 이용하여 전기 에너지를 빛 에너지로 전환하기 위한 소자로서, 애노드(anode)와 캐소드(cathode) 사이에 발광 가능한 유기물층이 형성된 구조를 포함한다.The organic light emitting device includes a structure in which an organic layer capable of emitting light is formed between an anode and a cathode, for converting electric energy into light energy using an organic material.
유기발광소자는 다양한 구조로 형성될 수 있으며, 그 중 복수의 발광부가 적층된 텐덤(Tandem)형 유기발광소자가 연구되고 있다.Organic light emitting devices can be formed in various structures, and a tandem type organic light emitting device in which a plurality of light emitting units are stacked has been studied.
텐덤(Tandem)형 유기발광소자에서는 애노드와 캐소드 사이에는 발광층을 포함하는 발광부가 복수 개 적층된다. 인접한 발광부 사이에는 전하의 생성 및 이동을 위한 전하생성층이 위치한다.In the tandem type organic light emitting device, a plurality of light emitting portions including a light emitting layer are stacked between the anode and the cathode. Between the adjacent light emitting portions, a charge generating layer for generating and moving charges is located.
전하생성층은 낮은 구동전압과 높은 효율이 요구된다.The charge generating layer requires a low driving voltage and high efficiency.
본 발명은 기존의 재료보다 발광효율이 우수하고 열 안정성이 뛰어난 신규한 페난트롤린 유도체를 제공하는 것이며 또한 상기 페난트롤린 유도체가 유기층에 포함되어 소자의 구동전압을 낮추고 발광 효율이 개선된 유기전계발광소자를 제공하는 것이다. The present invention provides a novel phenanthroline derivative which is superior in luminous efficiency and thermal stability to a conventional material, and that the phenanthroline derivative is included in the organic layer to lower the driving voltage of the device, And to provide a light emitting element.
본 발명의 목적은 하기 화학식 1로 표시되는 페난트롤린 화합물에 의해 달성된다.The object of the present invention is achieved by a phenanthroline compound represented by the following general formula (1).
[화학식 1][Chemical Formula 1]
Figure PCTKR2017012707-appb-I000001
Figure PCTKR2017012707-appb-I000001
상기 화학식 1에서,In Formula 1,
R1은 치환 또는 치환되지 않는 탄소수 3 내지 60의 아릴기, 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 치환 혹은 치환되지 않은 5원 내지 60원 헤테로아릴기, 아릴아민기 및 2차 아민기로 구성된 군으로부터 선택된다.R 1 is a substituted or unsubstituted aryl group having 3 to 60 carbon atoms, a substituted or unsubstituted 5 to 60 membered heteroaryl group containing at least one hetero atom selected from nitrogen, oxygen and sulfur, an arylamine group and 2 / RTI > amine group.
상기 유기발광소자는 제1전극, 제2전극, 및 상기 제1전극과 제2전극 사이에 위치하는 1층 이상의 유기물층을 포함하며, 상기 유기물층 중 1층 이상은 본 발명에 따른 페난트롤린 화합물을 포함할 수 있다.The organic light emitting device includes a first electrode, a second electrode, and at least one organic layer positioned between the first electrode and the second electrode, wherein at least one of the organic layers includes the phenanthroline compound according to the present invention. .
상기 유기물층은 발광층, 정공주입층, 정공수송층, 및 정공주입 및 정공수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함할 수 있다.The organic material layer may include at least one layer selected from the group consisting of a light emitting layer, a hole injecting layer, a hole transporting layer, and a layer simultaneously injecting holes and transporting holes.
상기 유기물층은 발광층, 전자주입층, 전자수송층, 및 전자주입 및 전자수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함할 수 있다.The organic material layer may include at least one layer selected from the group consisting of a light emitting layer, an electron injecting layer, an electron transporting layer, and layers simultaneously performing electron injection and electron transport.
상기 유기물층은 적어도 하나의 전하생성층(Charge Generation Layer: CGL)을 포함할 수 있다.The organic layer may include at least one charge generation layer (CGL).
상기 전하생성층은 n형일 수 있다.The charge generation layer may be n-type.
또한, 본 발명의 목적은 제1전극; 제2전극; 및 상기 제1전극과 상기 제2전극 사이에 위치하며 제1발광층을 포함하는 제1발광부; 상기 제2전극과 상기 제1발광부 사이에 위치하며 제2발광층을 포함하는 제2발광부; 상기 제1발광부와 상기 제2발광부 사이에 위치하는 제1전하생성층을 포함하며, 상기 제1발광부, 제2발광부 및 제1전하생성층 중 적어도 하나의 층은 제1항 또는 제2항에 따른 페난트롤린 화합물을 포함하는 유기발광소자에 의해 달성될 수 있다.Also, an object of the present invention is to provide a plasma display panel comprising a first electrode; A second electrode; And a first light emitting unit disposed between the first electrode and the second electrode and including a first light emitting layer; A second light emitting portion located between the second electrode and the first light emitting portion and including a second light emitting layer; Wherein at least one layer of the first light emitting portion, the second light emitting portion, and the first charge generating layer includes a first charge generating layer disposed between the first light emitting portion and the second light emitting portion, Can be achieved by an organic light emitting device comprising the phenanthroline compound according to claim 2.
상기 유기발광소자는, 상기 제2전극과 상기 제2발광부 사이에 위치하며 제3발광층을 포함하는 제3발광부; 및 상기 제2발광부와 상기 제3발광부 사이에 위치하는 제2전하생성층을 더 포함하며, 상기 제3발광부 및 제2전하생성층 중 적어도 하나의 층은 제1항 또는 제2항에 따른 페난트롤린 화합물을 포함할 수 있다.The organic light emitting device may further include: a third light emitting portion positioned between the second electrode and the second light emitting portion and including a third light emitting layer; And a second charge generation layer disposed between the second light emitting portion and the third light emitting portion, wherein at least one layer of the third light emitting portion and the second charge generation layer is formed of the first or second light emitting portion, Lt; RTI ID = 0.0 > phenanthroline < / RTI >
본 발명에 따른 페난트롤린 유도체는 유기 전계발광 소자의 유기층, 바람직하게는 전하생성층에 포함되어 소자의 구동전압을 낮추고 발광 효율을 개선할 수 있다. 또한, 본 발명의 페난트롤린 유도체의 열적 안정성에 의해 유기 전계발광 소자의 수명을 개선할 수 있다.The phenanthroline derivative according to the present invention may be included in an organic layer, preferably a charge generation layer, of an organic electroluminescent device, thereby lowering the driving voltage of the device and improving the luminous efficiency. Further, the lifetime of the organic electroluminescent device can be improved by the thermal stability of the phenanthroline derivative of the present invention.
도 1은 본 발명의 일 실시예에 따른 유기발광소자의 단면도이다.1 is a cross-sectional view of an organic light emitting diode according to an embodiment of the present invention.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 상세하게 후술되어 있는 실시예들을 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예들에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 것이며, 단지 본 실시예들은 본 발명의 개시가 완전하도록 하며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이며, 본 발명은 청구항의 범주에 의해 정의될 뿐이다. Advantages and features of the present invention and methods of achieving them will become apparent with reference to the embodiments described in detail below. The present invention may, however, be embodied in many different forms and should not be construed as being limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. Is provided to fully convey the scope of the invention to those skilled in the art, and the invention is only defined by the scope of the claims.
도면에서 나타난 각 구성의 크기 및 두께는 설명의 편의를 위해 도시된 것이며, 본 발명이 도시된 구성의 크기 및 두께에 반드시 한정되는 것은 아니다.The sizes and thicknesses of the individual components shown in the figures are shown for convenience of explanation and the present invention is not necessarily limited to the size and thickness of the components shown.
이하, 첨부된 도면을 참조하여 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
본 발명에 따른 페난트롤린 화합물은 화학식 1로 표시된다.The phenanthroline compound according to the present invention is represented by the formula (1).
[화학식 1][Chemical Formula 1]
Figure PCTKR2017012707-appb-I000002
Figure PCTKR2017012707-appb-I000002
상기 화학식 1에서,In Formula 1,
R1은 치환 또는 치환되지 않는 탄소수 3 내지 60의 아릴기, 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 치환 혹은 치환되지 않은 5원 내지 60원 헤테로아릴기, 아릴아민기 및 2차 아민기로 구성된 군으로부터 선택된다.R 1 is a substituted or unsubstituted aryl group having 3 to 60 carbon atoms, a substituted or unsubstituted 5 to 60 membered heteroaryl group containing at least one hetero atom selected from nitrogen, oxygen and sulfur, an arylamine group and 2 / RTI > amine group.
화학식 1로 표시되는 화합물은 하기 표시되는 화합물로 이루어진 군으로부터 선택될 수 있다.The compound represented by the formula (1) may be selected from the group consisting of the compounds shown below.
Figure PCTKR2017012707-appb-I000003
Figure PCTKR2017012707-appb-I000003
Figure PCTKR2017012707-appb-I000004
Figure PCTKR2017012707-appb-I000004
상기 화학식 1에서 페난트롤린 코어(Core)는 질소 원자 2개를 포함하고 2번 또는 8번 위치에 전자가 풍부한 아로마틱 화합물(Aromatic Compound)을 도입하여 질소 원자의 전자가 더욱 풍부해지므로 더욱 빠른 전자 이동도에 의해 전자 이송이 용이하게 된다. 이와 더불어 N형 전하생성층(N-CGL)에서 sp2 혼성 오비탈의 질소가 포함되며, 이러한 질소는 N형 전하생성층의 도펀트인 알칼리 금속 또는 알칼리 토금속과 결합하여 갭 스테이트(Gap state)를 형성한다. 따라서, 갭 스테이트에 의해 P형 전하생성층(P-CGL)에서 N형 전하생성층(N-CGL)으로 전자를 원활하게 전달할 수 있다.The phenanthroline core in the above formula (1) contains two nitrogen atoms and introduces an aromatic compound (Aromatic Compound) at the position 2 or 8 to enrich the electrons of the nitrogen atom, The electron transfer is facilitated by the mobility. In addition, nitrogen of the sp2 hybrid orbital is included in the N-type charge generation layer (N-CGL), and this nitrogen bonds with an alkali metal or an alkaline earth metal which is a dopant of the N-type charge generation layer to form a gap state . Therefore, electrons can be smoothly transferred from the P-type charge generation layer (P-CGL) to the N-type charge generation layer (N-CGL) by the gap state.
또한, 상기와 같은 구조의 코어 구조에 다양한 치환기를 도입함으로써 도입된 치환기의 고유 특성을 갖는 화합물을 합성할 수 있다. 예컨대, 유기 발광 소자 제조 시 사용되는 정공주입층 물질, 정공수송층 물질들은 HOMO(highest occupied molecular orbital)을 따라 정공을 전달해 줄 수 있을 만큼의 에너지 준위를 갖게 하며, 발광층으로부터 LUMO(lowest unoccupied molecular orbital)을 따라 넘어오는 전자를 막아 줄 정도의 에너지 준위를 가질 수 있는 화합물이 될 수 있다. 특히, 본 화합물의 코어 구조는 전자에 안정적인 특성을 보여 소자의 수명 향상에 기여할 수 있다. 발광층 및 전자 수송층 물질에 사용되도록 치환체들을 도입하여 이루어진 유도체들은 다양한 아릴아민계 도펀트, 아릴계 도펀트, 금속을 함유한 도펀트 등에 적당한 에너지 밴드갭을 갖도록 제조가 가능하다.Further, by introducing various substituents into the core structure having the above structure, it is possible to synthesize a compound having the intrinsic characteristics of the substituent introduced. For example, the hole injection layer material and the hole transport layer material used in the production of an organic light emitting device have energy levels enough to transfer holes along HOMO (highest occupied molecular orbital), and the lowest unoccupied molecular orbital (LUMO) A compound capable of having an energy level enough to block the electrons passing through the electron transporting layer. Particularly, the core structure of the present compound exhibits stable characteristics in terms of electrons, which can contribute to improvement of lifetime of the device. The derivatives prepared by introducing the substituents to be used for the light emitting layer and the electron transporting layer material can be manufactured to have appropriate energy band gaps for various arylamine type dopants, aryl type dopants, metal containing dopants and the like.
또한, 상기 코어 구조에 다양한 치환기를 도입함으로써 에너지 밴드갭의 미세한 조절이 가능하며, 한편으로 유기물 사이에서의 계면 특성을 향상시키며 물질의 용도를 다양하게 할 수 있다. Further, by introducing various substituent groups into the core structure, it is possible to finely control the energy band gap, improve the interfacial characteristics between the organic materials, and diversify the uses of the materials.
한편, 상기 화학식 1로 표시되는 화합물들은 유리 전이 온도(Tg)가 높아 열적 안정성이 우수하다. 이러한 열적안정성의 증가는 소자에 구동 안정성을 제공하는 중요한 요인이 된다. On the other hand, the compounds represented by Formula 1 have high glass transition temperature (Tg) and thus are excellent in thermal stability. This increase in thermal stability is an important factor in providing drive stability to the device.
도 1은 본 발명의 일 실시예에 따른 유기발광소자의 단면도이다. 도 1을 참조하면, 유기발광소자(1)는 탄뎀형 구조로서 제1전극(양극, 110), 제2전극(음극, 120), 제1발광부(210), 제2발광부(220), 제3발광부(230), 제1전하생성층(240) 및 제2전하생성층(250)을 포함한다.1 is a cross-sectional view of an organic light emitting diode according to an embodiment of the present invention. Referring to FIG. 1, the organic light emitting diode 1 includes a first electrode (anode) 110, a second electrode (cathode) 120, a first light emitting portion 210, a second light emitting portion 220, A third light emitting portion 230, a first charge generating layer 240, and a second charge generating layer 250.
제1발광부(210), 제2발광부(220), 제3발광부(230), 제1전하생성층(240) 및 제2전하생성층(250)은 유기물층으로서 제1전극(110)과 제2전극(120) 사이에 위치하며, 제1전하생성층(240)은 제1발광부(210)와 제2발광부(220) 사이에 위치하고,제2전하생성층(250)은 제2발광부(220)와 제3발광부(230)사이에 위치한다.The first charge generating layer 240 and the second charge generating layer 250 may include a first electrode 110 as an organic material layer and a second charge generating layer 250. The first light emitting portion 210, the second light emitting portion 220, the third light emitting portion 230, The first charge generating layer 240 is located between the first light emitting portion 210 and the second light emitting portion 220 and the second charge generating layer 250 is located between the first electrode 250 and the second electrode 120, 2 light-emitting portion 220 and the third light-emitting portion 230, respectively.
제1발광부(210)는 정공주입층(211), 제1정공수송층(212), 제1발광층(213), 제1전자수송층(214)으로 이루어져 있으며, 제2발광부(220)는 제2정공수송층(221), 제2발광층(222) 및 제2전자수송층(223)으로 이루어져 있고, 제3발광부(230)는 제3정공수송층(231), 제3발광층(232), 제3전자수송층(233) 및 전자주입층(234)으로 이루어져 있다.The first light emitting portion 210 includes a hole injection layer 211, a first hole transporting layer 212, a first light emitting layer 213 and a first electron transporting layer 214, The second light emitting layer 222 and the second electron transporting layer 223. The third light emitting portion 230 includes the third hole transporting layer 231, the third light emitting layer 232, the third hole transporting layer 231, An electron transport layer 233, and an electron injection layer 234.
제1전하생성층(240)은 n형 전하생성층(241)과 p형 전하생성층(242)으로 이루어져 있으며,제2전하생성층(250)은 n형 전하생성층(251)과 p형 전하생성층(252)으로 이루어져 있다. n형 전하생성층(241, 251)은 알칼리 금속으로 도핑되어 있을 수 있다.The first charge generating layer 240 is composed of an n-type charge generating layer 241 and a p-type charge generating layer 242. The second charge generating layer 250 is composed of an n-type charge generating layer 251 and a p- And a charge generation layer 252. The n-type charge generation layers 241 and 251 may be doped with an alkali metal.
본 발명에 따른 페난트롤린 화합물은 제1전자수송층(214), 제2전자수송층(223), 제3전자수송층(233), 전자주입층(234),제1전하생성층(240) 및/또는 제2전하생성층(250)에 포함되어 사용될 수 있으며, 특히 n형 전하생성층(241, 251)에 사용될 수 있다.The phenanthroline compound according to the present invention may be used in combination with a first electron transport layer 214, a second electron transport layer 223, a third electron transport layer 233, an electron injection layer 234, a first charge generation layer 240 and / Or the second charge generating layer 250, and can be used for the n-type charge generating layers 241 and 251 in particular.
설명한 유기발광소자(1)는 다양하게 변형가능하다. 일부 유기층은 생략되거나 추가될 수 있으며, 텐덤형태가 아닐 수 있으며, 2개 또는 4개 이상의 발광층을 가지는 텐덤형태일 수도 있다. 또한,유기발광소자(1)는 전자수송과 전자주입을 동시에 하는 층을 포함하는 유기층을 포함할 수 있으며,이러한 경우에도 본 발명에 따른 페난트롤린 화합물이 사용될 수 있다.The organic light emitting element 1 described above can be variously modified. Some organic layers may be omitted or added, may not be tandem-shaped, and may be in a tandem form having two or four or more light-emitting layers. In addition, the organic light emitting device 1 may include an organic layer including a layer simultaneously performing electron transport and electron injection, and in this case, the phenanthroline compound according to the present invention may also be used.
이하에서는 본 발명에 따른 페난트롤린 화합물의 제조예 및 유기발광소자의 실시예 및 비교예를 설명한다. 다만, 하기에 기재된 제조예 및 실시예는 본 발명을 구체적으로 예시하거나 설명하기 위한 것일 뿐이며, 이하에 기재된 제조예 및 실시예에 의해 본 발명을 제한하여 해석해서는 안 된다.Hereinafter, a production example of the phenanthroline compound according to the present invention, and examples and comparative examples of the organic light emitting device will be described. However, the following Production Examples and Examples are intended only to illustrate or explain the present invention, and the present invention should not be construed to be limited by the following Production Examples and Examples.
화합물 1-2의 제조예Production Example of Compound 1-2
상기 화합물 1-2로 표시된 2-(3-(나프탈렌-2-일)-5-(페난트렌-9-일)페닐)-1,10-페난트롤린을 아래와 같은 반응들을 이용해 제조하였다.2- (3- (naphthalen-2-yl) -5- (phenanthrene-9-yl) phenyl) -1,10-phenanthroline represented by the above compound 1-2 was prepared using the following reactions.
중간체 A(1-(3-브로모-5-(페난트렌-9-일)페닐)에타논)의 합성Synthesis of Intermediate A (1- (3-bromo-5- (phenanthren-9-yl) phenyl) ethanone)
Figure PCTKR2017012707-appb-I000005
Figure PCTKR2017012707-appb-I000005
둥근 바닥 플라스크에 3,5-디브로모아세토페논(50 g, 180mmole), 페난트렌-9-일보론산(20 g, 90 mmole), 테트라키스(트리페닐포스핀)팔라듐(0)(3.1 g, 3%), 탄산칼륨(37 g, 270 mmol), 톨루엔 200 ml, 에탄올 100 ml, 물 100 ml를 넣고 12 시간동안 환류 교반시켰다. 반응 종료 후 반응액을 염화메틸렌으로 추출하여 유기층만 분리하여 MgSO4로 건조시켰다. 헥산으로 컬럼정제를 하고 용매를 제거하여 중간체 A(수율 62%)를 수득하였다.A round bottom flask was charged with 3,5-dibromoacetophenone (50 g, 180 mmole), phenanthrene-9-ylboronic acid (20 g, 90 mmole), tetrakis (triphenylphosphine) palladium (0) , 3%), potassium carbonate (37 g, 270 mmol), toluene (200 ml), ethanol (100 ml), and water (100 ml) were stirred under reflux for 12 hours. After completion of the reaction, the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 . Column purification was carried out with hexane and the solvent was removed to give intermediate A (yield 62%).
1H NMR(300 MHz, CDCl3, ppm): δ 8.79(tt, 1H), 8.74(dd, 1H), 8.18(t, 1H), 8.05(t, 1H), 7.92-7.89(m, 2H), 7.78(dd, 1H), 7.73-7.69(m, 2H), 7.68(s, 1H), 7.86-7.56(m, 2H), 2.64(s,3H); EI, MS m/z(%): 375(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 8.79 (tt, 1H), 8.74 (dd, 1H), 8.18 (t, 1H), 8.05 (t, 1H), 7.92-7.89 (m, 2H) , 7.78 (dd, 1H), 7.73-7.69 (m, 2H), 7.68 (s, 1H), 7.86-7.56 (m, 2H), 2.64 (s, 3H); EI, MS m / z (%): 375 (100, M < + &
중간체 B(1-(3-(나프탈렌-2-일)-5-(페난트렌-9-일)페닐)에타논)의 합성Synthesis of Intermediate B (1- (3- (naphthalen-2-yl) -5- (phenanthren-9-yl) phenyl) ethanone)
Figure PCTKR2017012707-appb-I000006
Figure PCTKR2017012707-appb-I000006
둥근 바닥 플라스크에 중간체 A(11 g, 29 mmole), 나프탈렌-2-일보론산(6 g, 35.1 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(1g, 3%), 탄산칼륨(12 g, 87.9 mmol), 톨루엔 110ml, 에탄올 55ml, 물 55 ml를 넣고 6 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 염화메틸렌으로 추출하여 유기층만 분리하여 MgSO4로 건조하였다. 염화메틸렌으로 컬럼정제를 하고 용매를 제거하여 중간체 B(수율 89%)를 수득하였다A round bottom flask was charged with intermediate A (11 g, 29 mmole), naphthalene-2-ylboronic acid (6 g, 35.1 mmole), tetrakis (triphenylphosphine) palladium (0) (1 g, 3% 12 g, 87.9 mmol), 110 ml of toluene, 55 ml of ethanol and 55 ml of water were added and the mixture was stirred under reflux for 6 hours. After completion of the reaction, the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 . Column purification was carried out with methylene chloride and the solvent was removed to give Intermediate B (89% yield)
1H NMR(300 MHz, CDCl3, ppm): δ 8.82(d, 1H), 8.76(d, 1H), 8.44(t, 1H), 8.17(d, 1H), 8.14(t, 1H), 8.13(t, 1H), 7.97-7.88(m, 5H), 7.85(dd, 1H), 7.79(s, 1H), 7.73-7.70(m, 2H), 7.67-7.64(m, 1H), 7.60-7.56(m, 1H), 7.54-7.49(m, 2H), 2.74(s,3H); EI, MS m/z(%): 422(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 8.82 (d, 1H), 8.76 (d, 1H), 8.44 (t, 1H), 8.17 (d, 1H), 8.14 (t, 1H), 8.13 (m, 2H), 7.67-7.64 (m, 1H), 7.60-7.56 (m, (m, 1 H), 7.54-7.49 (m, 2 H), 2.74 (s, 3 H); EI, MS m / z (%): 422 (100, M < + &
화합물 1-2 2-(3-(나프탈렌-2-일)-5-(페난트렌-9-일)페닐)-1,10-페난트롤린의 합성Compound 1-2 Synthesis of 2- (3- (naphthalen-2-yl) -5- (phenanthrene-9-yl) phenyl) -1,10-phenanthroline
Figure PCTKR2017012707-appb-I000007
Figure PCTKR2017012707-appb-I000007
둥근 바닥 플라스크에 중간체 B(11 g, 26 mmole), 8-아미노퀴놀린-7-카르브알데히드(5.4 g, 31 mmole), 수산화칼륨(4.4 g, 78 mmol), 톨루엔 110 ml, 에탄올 55 ml를 넣고 12 시간 동안 환류 교반시켰다. 반응 종료 후 과량의 메탄올로 석출하고 여과 건조하였다. 염화메틸렌으로 컬럼정제를 하고 용매를 제거하여 화합물 1-2(수율 77%)를 수득하였다A round bottom flask was charged with Intermediate B (11 g, 26 mmole), 8-aminoquinoline-7-carbaldehyde (5.4 g, 31 mmole), potassium hydroxide (4.4 g, 78 mmol), toluene 110 ml, And the mixture was refluxed for 12 hours. After completion of the reaction, the reaction mixture was precipitated with an excess amount of methanol, followed by filtration and drying. The column was purified with methylene chloride and the solvent was removed to obtain Compound 1-2 (yield 77%)
1H NMR(300 MHz, CDCl3, ppm): δ 9.19(dd, 1H), 8.82(d, 1H), 8.80(t, 1H), 8.77(d, 1H), 8.42(t, 1H), 8.36(d, 1H), 8.30(s, 1H), 8.26(dd, 1H), 8.23(d, 1H), 8.09(dd, 1H), 8.03(t, 1H), 8.00-7.88(m, 6H), 7.82(dd, 2H), 7.72-7.68(m, 2H), 7.66-7.62(m, 1H), 7.53-7.48(m, 2H); EI, MS m/z(%): 558(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 9.19 (dd, 1H), 8.82 (d, 1H), 8.80 (t, 1H), 8.77 (d, 1H), 8.42 (t, 1H), 8.36 (d, IH), 8.03 (t, IH), 8.00-7.88 (m, 6H) 7.82 (dd, 2H), 7.72-7.68 (m, 2H), 7.66-7.62 (m, 1H), 7.53-7.48 (m, 2H); EI, MS m / z (%): 558 (100, M < + &
화합물 1-8의 제조예Preparation Example of Compound 1-8
상기 화합물 1-8로 표시된 2-(3-(페난트렌-9-일)-5-(퀴놀린-3-일)페닐)-1,10-페난트롤린을 아래와 같은 반응들을 이용해 제조하였다.2- (3- (Phenanthren-9-yl) -5- (quinolin-3-yl) phenyl) -1,10-phenanthroline represented by the above compound 1-8 was prepared using the following reactions.
중간체 C 1-(3-(페난트렌-9-일)-5-(퀴놀린-3-일)페닐)에타논의 합성 Intermediate C Synthesis of 1- (3- (phenanthren-9-yl) -5- (quinolin-3-yl) phenyl)
Figure PCTKR2017012707-appb-I000008
Figure PCTKR2017012707-appb-I000008
둥근 바닥 플라스크에 중간체 A(10 g, 26 mmole), 퀴놀린-3-일보론산(5.5 g, 31.9 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(0.9 g, 3%), 탄산칼륨(11 g, 79.9 mmol), 톨루엔 100 ml, 에탄올 50 ml, 물 50 ml를 넣고 3 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 염화메틸렌으로 추출하여 유기층만 분리하여 MgSO4로 건조하였다. 염화메틸렌으로 컬럼정제를 하고 용매를 제거하여 중간체 C(수율 88%)를 수득하였다.To a round bottom flask was added intermediate A (10 g, 26 mmole), quinoline-3-ylboronic acid (5.5 g, 31.9 mmole), tetrakis (triphenylphosphine) palladium (0) (11 g, 79.9 mmol), toluene (100 ml), ethanol (50 ml) and water (50 ml), and the mixture was refluxed for 3 hours. After completion of the reaction, the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 . Column purification was carried out with methylene chloride and the solvent was removed to give Intermediate C (yield 88%).
1H NMR(300 MHz, CDCl3, ppm): δ 9.28(d, 1H), 8.82(dd, 1H), 8.76(dd, 1H), 8.44(d, 1H), 8.42(t, 1H), 8.16(d, 1H), 8.11(t, 1H), 7.97(dd, 1H), 7.91(s, 1H), 7.89(s, 1H),7.79(s, 1H), 7.77-7.57(m, 6H), 2.74(s,3H); EI, MS m/z(%): 423(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 9.28 (d, 1H), 8.82 (dd, 1H), 8.76 (dd, 1H), 8.44 (d, 1H), 8.42 (t, 1H), 8.16 (d, IH), 8.11 (t, IH), 7.97 (dd, IH), 7.91 (s, IH), 7.89 2.74 (s, 3 H); EI, MS m / z (%): 423 (100, M < + &
화합물 1-82-(3-(페난트렌-9-일)-5-(퀴놀린-3-일)페닐)-1,10-페난트롤린의 합성 Synthesis of Compound 1-82- (3- (Phenanthrene-9-yl) -5- (quinolin-3-yl) phenyl) -1,10-phenanthroline
Figure PCTKR2017012707-appb-I000009
Figure PCTKR2017012707-appb-I000009
둥근 바닥 플라스크에 중간체 C(10 g, 23 mmole), 8-아미노퀴놀린-7-카르브알데히드(4.8 g, 28 mmole), 수산화칼륨(4 g, 71 mmol), 톨루엔 100 ml, 에탄올 50 ml를 투입하고 12 시간 동안 환류 교반시켰다. 반응 종료 후 과량의 메탄올로 석출하고 여과 건조하였다. 염화메틸렌으로 컬럼정제를 하고 용매를 제거하여 화합물 1-8(수율 82%)을 수득하였다.A round bottom flask was charged with Intermediate C (10 g, 23 mmole), 8-aminoquinoline-7-carbaldehyde (4.8 g, 28 mmole), potassium hydroxide (4 g, 71 mmol), toluene 100 ml and ethanol 50 ml And the mixture was refluxed for 12 hours. After completion of the reaction, the reaction mixture was precipitated with an excess amount of methanol, followed by filtration and drying. Column purification was performed with methylene chloride, and the solvent was removed to obtain Compound 1-8 (yield 82%).
1H NMR(300 MHz, CDCl3, ppm): δ9.42(d, 1H), 9.19(dd, 1H), 8.83-8.76(m, 3H), 8.57(d, 1H), 8.44(t, 1H), 8.36(d, 1H), 8.26(dd, 1H), 8.21(d, 1H), 8.17(d, 1H), 8.04(dd, 1H), 8.01(t, 1H), 7.97-7.91(m, 3H), 7.82(q, 2H), 7.76-7.69(m, 3H), 7.67-7.63(m, 2H), 7.57(m, 2H); EI, MS m/z(%): 559(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ9.42 (d, 1H), 9.19 (dd, 1H), 8.83-8.76 (m, 3H), 8.57 (d, 1H), 8.44 (t, 1H 1H), 8.14 (d, 1H), 8.04 (dd, 1H), 8.01 (t, 1H), 7.97-7.91 (m, 3H), 7.82 (q, 2H), 7.76-7.69 (m, 3H), 7.67-7.63 (m, 2H), 7.57 (m, 2H); EI, MS m / z (%): 559 (100, M < + &
화합물 1-10의 제조예Production Example of Compound 1-10
상기 화합물 1-10로 표시된 2-(3-(페난트렌-9-일)-5-(피리미딘-2-일)페닐)-1,10-페난트롤린을 아래와 같은 반응들을 이용해 제조하였다.2- (3- (Phenanthren-9-yl) -5- (pyrimidin-2-yl) phenyl) -1,10-phenanthroline represented by the above Compound 1-10 was prepared using the following reactions.
중간체 D(1-(3-(페난트렌-9-일)-5-(피리미딘-2-일)페닐)에타논) 의 합성Synthesis of Intermediate D (1- (3- (phenanthren-9-yl) -5- (pyrimidin-2-yl) phenyl) ethanone)
Figure PCTKR2017012707-appb-I000010
Figure PCTKR2017012707-appb-I000010
둥근 바닥 플라스크에 중간체 A(10 g, 26 mmole), 2-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일)피리미딘(6.6 g, 31.9 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(0.9 g, 3%), 탄산칼륨(11 g, 79.9 mmol), 톨루엔 100 ml, 에탄올 50 ml, 물 50 ml를 넣고 3 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 염화메틸렌으로 추출하여 유기층만 분리하여 MgSO4로 건조하였다. 염화메틸렌으로 컬럼정제를 하고 용매를 제거하여 중간체 D(수율 62%)를 수득하였다To a round bottom flask was added intermediate A (10 g, 26 mmole), 2- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) pyrimidine (6.6 g, 31.9 (0.9 g, 3%), potassium carbonate (11 g, 79.9 mmol), toluene (100 ml), ethanol (50 ml) and water (50 ml) Lt; / RTI > After completion of the reaction, the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 . Column purification was performed with methylene chloride and the solvent was removed to obtain Intermediate D (yield 62%)
1H NMR(300 MHz, CDCl3, ppm): δ 8.82(d, 1H), 8.76(d, 1H), 8.35(t, 1H), 8.13(t, 1H), 8.04(t, 1H), 7.92(dddd, 2H), 7.83(s, 2H), 7.77(s, 1H), 7.73-7.66(m, 2H), 7.65(ddd, 1H), 7.58-7.56(m, 1H), 2.72(s,3H); EI, MS m/z(%): 374(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 8.82 (d, 1H), 8.76 (d, 1H), 8.35 (t, 1H), 8.13 (t, 1H), 8.04 (t, 1H), 7.92 (m, 2H), 7.72 (s, 1H), 7.72 (s, 1H) ); EI, MS m / z (%): 374 (100, M < + &
화합물 1-10 2-(3-(페난트렌-9-일)-5-(피리미딘-2-일)페닐)-1,10-페난트롤린의 합성 Compound 1-10 Synthesis of 2- (3- (phenanthrene-9-yl) -5- (pyrimidin-2-yl) phenyl) -1,10-phenanthroline
Figure PCTKR2017012707-appb-I000011
Figure PCTKR2017012707-appb-I000011
둥근 바닥 플라스크에 중간체 D(6 g, 16 mmole), 8-아미노퀴놀린-7-카르브알데히드(3.3 g, 19 mmole), 수산화칼륨(2.7 g, 48 mmol), 톨루엔 60 ml, 에탄올 30 ml를 투입하고 12 시간 동안 환류 교반시켰다. 반응 종료 후 과량의 메탄올로 석출하고 여과 건조하였다. 염화메틸렌으로 컬럼정제를 하고 용매를 제거하여 화합물 1-10(수율 91%)을 수득하였다.To a round bottom flask was added Intermediate D (6 g, 16 mmole), 8-aminoquinoline-7-carbaldehyde (3.3 g, 19 mmole), potassium hydroxide (2.7 g, 48 mmol), 60 ml of toluene and 30 ml of ethanol And the mixture was refluxed for 12 hours. After completion of the reaction, the reaction mixture was precipitated with an excess amount of methanol, followed by filtration and drying. Column purification was performed with methylene chloride, and the solvent was removed to obtain Compound 1-10 (yield 91%).
화합물 1-13의 제조예Production Example of Compound 1-13
상기 화합물 1-13로 표시된 2-(5-(페난트렌-9-일)-4'-(피리미딘-2-일)-[1,1'-비페닐]-3-일)-1,10-페난트롤린을 아래와 같은 반응들을 이용해 제조하였다.1 - (1,1'-biphenyl) -3-yl) -1, 2 '- (5- (phenanthrene- 10-phenanthroline was prepared using the following reactions.
중간체 E 9-(3-브로모-5-클로로페닐)페난트렌의 합성Intermediate E Synthesis of 9- (3-bromo-5-chlorophenyl) phenanthrene
Figure PCTKR2017012707-appb-I000012
Figure PCTKR2017012707-appb-I000012
둥근 바닥 플라스크에 1,3-디브로모-5-클로로벤젠(50 g, 184.9 mmole), 페난트렌-9-일보론산(20.5 g, 92.47 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(4.3 g, 4%), 탄산칼륨(51 g, 369.9 mmol), 톨루엔 500 ml, 에탄올 250 ml, 물 250 ml를 넣고 4 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 여과하여 크루드 상태의 생성물을 얻는다. 여과된 크루드를 MC에 가열하여 녹인 후 실리카겔에 컬럼정제를 하고 용매를 제거한 후 MC/EA을 사용하여 침전시켜 중간체 E(수율 61%)를 수득하였다.To a round bottom flask was added 1,3-dibromo-5-chlorobenzene (50 g, 184.9 mmole), phenanthrene-9-ylboronic acid (20.5 g, 92.47 mmole), tetrakis (triphenylphosphine) palladium ) (4.3 g, 4%), potassium carbonate (51 g, 369.9 mmol), toluene (500 ml), ethanol (250 ml) and water (250 ml) were added and stirred under reflux for 4 hours. After completion of the reaction, the reaction solution is filtered to obtain a crude product. The filtered crude was heated to dissolve in MC, and the column was purified on silica gel. The solvent was removed and precipitated using MC / EA to obtain Intermediate E (yield: 61%).
중간체 F 2-(3'-클로로-5'-(페난트렌-9-일)-[1,1'-비페닐]-4-일)피리미딘의 합성Intermediate F Synthesis of 2- (3'-chloro-5 '- (phenanthrene-9-yl) - [1,1'-biphenyl] -4-yl) pyrimidine
Figure PCTKR2017012707-appb-I000013
Figure PCTKR2017012707-appb-I000013
둥근 바닥 플라스크에 중간제 E(20 g, 54.4 mmole), (4-(피리미딘-2-일)페닐)보론산(16.1g, 57.1 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(2.5 g, 4%), 탄산칼륨(30 g, 217.6 mmol), 톨루엔 200 ml, 에탄올 100 ml, 물 100 ml를 넣고 6 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 여과하여 크루드 상태의 생성물을 얻는다. 여과된 크루드를 MC에 가열하여 녹인 후 실리카겔에 컬럼정제를 하고 용매를 제거한 후 MC/EA을 사용하여 침전시켜 중간체 F(수율 81%)를 수득하였다.(20 g, 54.4 mmole), (4- (pyrimidin-2-yl) phenyl) boronic acid (16.1 g, 57.1 mmole), tetrakis (triphenylphosphine) palladium (0) (2.5 g, 4%), potassium carbonate (30 g, 217.6 mmol), toluene (200 ml), ethanol (100 ml), and water (100 ml) were stirred and refluxed for 6 hours. After completion of the reaction, the reaction solution is filtered to obtain a crude product. The filtered crude was heated to dissolve in MC and purified by column chromatography on silica gel. The solvent was removed and precipitated using MC / EA to give Intermediate F (81% yield).
중간체 G 2-(3'-(페난트렌-9-일)-5'-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일)-[1,1'-비페닐]-4-일)피리미딘의 합성Intermediate G 2- (3 '- (Phenanthren-9-yl) -5' - (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- , 1'-biphenyl] -4-yl) pyrimidine
Figure PCTKR2017012707-appb-I000014
Figure PCTKR2017012707-appb-I000014
둥근 바닥 플라스크에 중간체 F(10g, 22.6 mmol), 비스(피나콜라토)디보론(7.5 g, 29.3 mmol), 탈라듐 아세테이트(253 mg, 5%), SPhos(930 mg, 1%), 인산칼륨(14 g, 67.8 mmol), 디옥산 50 ml를 넣고 4 시간 동안 환류 교반시킨다. 반응 종료 후 반응액을 MeOH, H2O, 아세톤을 이용하여 크루드 상태의 생성물을 얻는다. 이 크루드를 MC에 가열하여 녹인 후 실리카겔에 컬럼정제를 하고 용매를 제거한 후 MeOH을 사용하여 중간체 G(수율 83%)를 수득하였다. EI, MS m/z(%): 534(100, M+)To a round bottom flask was added intermediate F (10 g, 22.6 mmol), bis (pinacolato) diboron (7.5 g, 29.3 mmol), talladium acetate (253 mg, 5%), SPhos (930 mg, Potassium (14 g, 67.8 mmol) and dioxane (50 ml) were added and the mixture was stirred under reflux for 4 hours. After completion of the reaction, the crude product is obtained by using MeOH, H 2 O and acetone as the reaction mixture. The crude product was dissolved in MC by heating. The silica gel was purified by silica gel, and the solvent was removed. MeOH was used to obtain Intermediate G (yield: 83%). EI, MS m / z (%): 534 (100, M < + &
화합물 1-13 2-(5-(페난트렌-9-일)-4'-(피리미딘-2-일)-[1,1'-비페닐]-3-일)-1,10-페난트롤린의 합성Compound 1-13 2- (5- (Phenanthren-9-yl) -4'- (pyrimidin-2-yl) - [1,1'-biphenyl] -3- Synthesis of troline
Figure PCTKR2017012707-appb-I000015
Figure PCTKR2017012707-appb-I000015
둥근 바닥 플라스크에 중간체 G(10 g, 18.7 mmole), 2-브로모-1,10-페난트롤린(5.3 g, 57.1 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(870 mg, 4%), 탄산칼륨(10 g, 74.8 mmol), 톨루엔 100 ml, 에탄올 50 ml, 물 50 ml를 넣고 5 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 여과하여 크루드 상태의 생성물을 얻었다. 여과된 크루드를 MC에 가열하여 녹인 후 실리카겔에 컬럼정제를 하고 용매를 제거한 후 MC/EA을 사용하여 침전시켜 화합물 1-13(수율 57.4%)을 수득하였다.To a round bottom flask was added Intermediate G (10 g, 18.7 mmole), 2-bromo-1,10-phenanthroline (5.3 g, 57.1 mmole), tetrakis (triphenylphosphine) palladium (0) 4%), potassium carbonate (10 g, 74.8 mmol), toluene (100 ml), ethanol (50 ml) and water (50 ml) were added and stirred under reflux for 5 hours. After completion of the reaction, the reaction solution was filtered to obtain a crude product. The filtered crude was heated to dissolve in MC and purified by column chromatography on silica gel. The solvent was removed and precipitated using MC / EA to give compound 1-13 (yield: 57.4%).
1H NMR(300 MHz, CDCl3, ppm): 9.19(dd, 1H), 8.84(d, 2H), 8.77(dd, 2H), 8.71(t, 1H), 8.57(tt, 2H), 8.43(t, 1H), 8.35(d, 1H), 8.25(dd, 1H), 8.217(d, 1H), 8.05(dd, 1H), 7.98-7.94(m, 4H), 7.89(s, 1H), 7.814(dd, 2H), 7.72-7.68(m, 2H), 7.66-7.62(m, 2H), 7.51(dtd, 1H), 7.2(t, 1H); EI, MS m/z(%): 586(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): 9.19 (dd, 1H), 8.84 (d, 2H), 8.77 (dd, 2H), 8.71 (t, 1H), 8.57 (tt, 2H), 8.43 ( (d, IH), 7.98-7.94 (m, 4H), 7.89 (s, IH), 7.814 (dd, 2H), 7.72-7.68 (m, 2H), 7.66-7.62 (m, 2H), 7.51 (dd, 1H), 7.2 (t, 1H); EI, MS m / z (%): 586 (100, M < + &
화합물 1-16의 제조예Production Example of Compound 1-16
상기 화합물 1-16로 표시된 2-(3-(페난트렌-9-일)-5-(4-(피리미딘-2-일)나프탈렌-1-일)페닐)-1,10-페난트롤린을 아래와 같은 반응들을 이용해 제조하였다.(3- (phenanthren-9-yl) -5- (4- (pyrimidin-2-yl) naphthalen-1-yl) phenyl) -1,10-phenanthroline Was prepared using the following reactions.
중간체 A(1-(3-브로모-5-(페난트렌-9-일)페닐)에타논)의 합성Synthesis of Intermediate A (1- (3-bromo-5- (phenanthren-9-yl) phenyl) ethanone)
Figure PCTKR2017012707-appb-I000016
Figure PCTKR2017012707-appb-I000016
둥근 바닥 플라스크에 3,5-디브로모아세토페논(50 g, 180 mmole), 페난트렌-9-일보론산(20 g, 90 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(3.1 g, 3%),탄산칼륨(37 g, 270 mmol), 톨루엔 200 ml, 에탄올 100 ml, 물 100 ml를 넣고 12 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 염화메틸렌으로 추출하여 유기층만 분리하여 MgSO4로 건조하였다. 헥산으로 컬럼정제를 하고 용매를 제거하여 중간체 A(수율 62%)를 수득하였다.To a round bottom flask was added 3,5-dibromoacetophenone (50 g, 180 mmole), phenanthrene-9-ylboronic acid (20 g, 90 mmole), tetrakis (triphenylphosphine) palladium g, 3%), potassium carbonate (37 g, 270 mmol), toluene (200 ml), ethanol (100 ml), and water (100 ml) were stirred at reflux for 12 hours. After completion of the reaction, the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 . Column purification was carried out with hexane and the solvent was removed to give intermediate A (yield 62%).
1H NMR(300 MHz, CDCl3, ppm): δ 8.79(tt, 1H), 8.74(dd, 1H), 8.18(t, 1H), 8.05(t, 1H), 7.92-7.89(m, 2H), 7.78(dd, 1H), 7.73-7.69(m, 2H), 7.68(s, 1H), 7.86-7.56(m, 2H), 2.64(s,3H); EI, MS m/z(%): 375(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 8.79 (tt, 1H), 8.74 (dd, 1H), 8.18 (t, 1H), 8.05 (t, 1H), 7.92-7.89 (m, 2H) , 7.78 (dd, 1H), 7.73-7.69 (m, 2H), 7.68 (s, 1H), 7.86-7.56 (m, 2H), 2.64 (s, 3H); EI, MS m / z (%): 375 (100, M < + &
중간체 H 1-(3-(페난트렌-9-일)-5-(4-(피리미딘-2-일)나프탈렌-1-일)페닐)에타논의 합성 Synthesis of Intermediate H Synthesis of 1- (3- (phenanthren-9-yl) -5- (4- (pyrimidin-2-yl) naphthalen-
Figure PCTKR2017012707-appb-I000017
Figure PCTKR2017012707-appb-I000017
둥근 바닥 플라스크에 중간체 A(9.5 g, 25 mmole), 2-(4-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일)나프탈렌-1-일)피리미딘(10 g, 30 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(0.9 g, 3%), 탄산칼륨(10.5 g, 75.3 mmol), 톨루엔 100 ml, 에탄올 50 ml, 물 50 ml를 넣고 12 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 염화메틸렌으로 추출하여 유기층만 분리하여 MgSO4로 건조하였다. 염화메틸렌으로 컬럼정제를 하고 용매를 제거하여 중간체 H(수율 94%)를 수득하였다.To a round bottom flask was added intermediate A (9.5 g, 25 mmole), 2- (4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene- (10 g, 30.3 mmol), tetrakis (triphenylphosphine) palladium (0) (0.9 g, 3%), potassium carbonate (10.5 g, 75.3 mmol), toluene 100 ml, ethanol 50 ml, 50 ml of water was added and the mixture was refluxed for 12 hours. After completion of the reaction, the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 . Column purification was carried out with methylene chloride and the solvent was removed to give Intermediate H (94% yield).
1H NMR(300 MHz, CDCl3, ppm): δ 8.98(s, 1H), 8.97(s, 1H), 8.81(d, 1H), 8.74(d, 1H), 8.70(d, 1H) 8.24(t, 1H), 8.22(t, 1H), 8.13(d, 1H), 8.05(d, 1H), 7.99(d, 1H), 7.94(t, 1H), 7.81(s, 1H), 7.72-7.68(m, 2H), 7.67-7.51(m, 6H), 7.34(t, 1H) 2.72(s, 3H); EI, MS m/z(%): 501(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 8.98 (s, 1H), 8.97 (s, 1H), 8.81 (d, 1H), 8.74 (d, 1H), 8.70 (d, 1H) 8.24 ( 1H), 7.81 (d, IH), 7.81 (d, IH), 7.81 (m, 2 H), 7.67-7.51 (m, 6 H), 7.34 (t, 1 H) 2.72 (s, 3 H); EI, MS m / z (%): 501 (100, M < + &
화합물 1-16 2-(3-(페난트렌-9-일)-5-(4-(피리미딘-2-일)나프탈렌-1-일)페닐)-1,10-페난트롤린의 합성Compound 1-16 Synthesis of 2- (3- (phenanthren-9-yl) -5- (4- (pyrimidin-2-yl) naphthalen-1-yl) phenyl) -1,10-phenanthroline
Figure PCTKR2017012707-appb-I000018
Figure PCTKR2017012707-appb-I000018
둥근 바닥 플라스크에 중간체 H(14 g, 28 mmole), 8-아미노퀴놀린-7-카르브알데히드(5.8 g, 33.6 mmole), 수산화칼륨(4.7 g, 84 mmol), 톨루엔 140 ml, 에탄올 70 ml를 넣고 5 시간 동안 환류 교반시켰다. 반응 종료 후 과량의 메탄올로 석출하고 여과 건조하였다. 염화메틸렌으로 컬럼정제를 하고 재결정하여 화합물 1-16(수율 82%)을 수득하였다.A round bottom flask was charged with Intermediate H (14 g, 28 mmole), 8-aminoquinoline-7-carbaldehyde (5.8 g, 33.6 mmole), potassium hydroxide (4.7 g, 84 mmol), toluene 140 ml, And the mixture was refluxed for 5 hours. After completion of the reaction, the reaction mixture was precipitated with an excess amount of methanol, followed by filtration and drying. Column purification was carried out with methylene chloride and recrystallization was conducted to obtain Compound 1-16 (yield: 82%).
1H NMR(300 MHz, CDCl3, ppm): δ 9.12(d, 1H), 8.98(s, 1H), 8.97(s, 1H), 8.80(d, 1H), 8.75(d, 1H), 8.71(d, 1H), 8.57(t, 1H) 8.51(t, 1H), 8.34(d, 1H), 8.25(dd, 1H), 8.19(d, 2H), 8.15(d, 2H), 7.94(t, 2H), 7.82(t, 2H), 7.78(t, 2H), 7.70-7.67(m, 2H), 7.65-7.49(m, 1H), 7.33(t, 1H); EI, MS m/z(%): 637(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 9.12 (d, 1H), 8.98 (s, 1H), 8.97 (s, 1H), 8.80 (d, 1H), 8.75 (d, 1H), 8.71 (d, 1H), 8.57 (t, 1H), 8.51 (t, 1H), 8.34 2H), 7.82 (t, 2H), 7.78 (t, 2H), 7.70-7.67 (m, 2H), 7.65-7.49 (m, 1H), 7.33 (t, 1H); EI, MS m / z (%): 637 (100, M < + &
화합물 1-17의 제조예Production Example of Compound 1-17
상기 화합물 1-17로 표시된 2-(3-(페난트렌-9-일)-5-(4-페닐나프탈렌-1-일)페닐)-1,10-페난트롤린을 아래와 같은 반응들을 이용해 제조하였다.(3- (phenanthrene-9-yl) -5- (4-phenylnaphthalen-1-yl) phenyl) -1,10-phenanthroline represented by the above compound 1-17 was synthesized by the following reactions Respectively.
중간체 A(1-(3-브로모-5-(페난트렌-9-일)페닐)에타논)의 합성 Synthesis of Intermediate A (1- (3-bromo-5- (phenanthren-9-yl) phenyl) ethanone)
Figure PCTKR2017012707-appb-I000019
Figure PCTKR2017012707-appb-I000019
둥근 바닥 플라스크에 3,5-디브로모아세토페논(50 g, 180 mmole), 페난트렌-9-일보론산(20 g, 90 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(3.1 g, 3%), 탄산칼륨(37 g, 270 mmol), 톨루엔 200 ml, 에탄올 100 ml, 물 100 ml를 넣고 12 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 염화메틸렌으로 추출하여 유기층만 분리하여 MgSO4로 건조하였다. 헥산으로 컬럼정제를 하고 용매를 제거하여 중간체 A(수율 62%)를 수득하였다.To a round bottom flask was added 3,5-dibromoacetophenone (50 g, 180 mmole), phenanthrene-9-ylboronic acid (20 g, 90 mmole), tetrakis (triphenylphosphine) palladium g, 3%), potassium carbonate (37 g, 270 mmol), toluene (200 ml), ethanol (100 ml), and water (100 ml) were stirred at reflux for 12 hours. After completion of the reaction, the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 . Column purification was carried out with hexane and the solvent was removed to give intermediate A (yield 62%).
1H NMR(300 MHz, CDCl3, ppm): δ 8.79(tt, 1H), 8.74(dd, 1H), 8.18(t, 1H), 8.05(t, 1H), 7.92-7.89(m, 2H), 7.78(dd, 1H), 7.73-7.69(m, 2H), 7.68(s, 1H), 7.86-7.56(m, 2H), 2.64(s,3H); EI, MS m/z(%): 375(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 8.79 (tt, 1H), 8.74 (dd, 1H), 8.18 (t, 1H), 8.05 (t, 1H), 7.92-7.89 (m, 2H) , 7.78 (dd, 1H), 7.73-7.69 (m, 2H), 7.68 (s, 1H), 7.86-7.56 (m, 2H), 2.64 (s, 3H); EI, MS m / z (%): 375 (100, M < + &
중간체 I 1-(3-(페난트렌-9-일)-5-(4-페닐나프탈렌-1-일)페닐)에타논의 합성Intermediate I Synthesis of 1- (3- (phenanthren-9-yl) -5- (4-phenylnaphthalen-1-yl) phenyl)
Figure PCTKR2017012707-appb-I000020
Figure PCTKR2017012707-appb-I000020
둥근 바닥 플라스크에 중간체 A(15 g, 40 mmole), 2(4-페닐나프탈렌-1-일)보론산(12 g, 48 mmole), 테트라키스(트리페닐포스핀) 팔라듐(0)(1.4 g, 3%), 탄산칼륨(16.6 g, 120 mmol), 톨루엔 150 ml, 에탄올 75 ml, 물 75 ml를 넣고 12 시간 동안 환류 교반시켰다. 반응 종료 후 반응액을 염화메틸렌으로 추출하여 유기층만 분리하여 MgSO4로 건조하였다. 헥산:아세트산에틸(10:1)로 컬럼정제를 하고 용매를 제거하여 중간체 I(수율 92%)를 수득하였다.To a round bottom flask was added intermediate A (15 g, 40 mmole), 2 (4-phenylnaphthalen-1-yl) boronic acid (12 g, 48 mmole), tetrakis (triphenylphosphine) palladium , 3%), potassium carbonate (16.6 g, 120 mmol), toluene (150 ml), ethanol (75 ml), and water (75 ml) were stirred under reflux for 12 hours. After completion of the reaction, the reaction solution was extracted with methylene chloride, and the organic layer was separated and dried with MgSO 4 . Column purification was carried out with hexane: ethyl acetate (10: 1) and the solvent was removed to give Intermediate I (92% yield).
1H NMR(300 MHz, CDCl3, ppm): δ 8.81(d, 1H), 8.74(d, 1H), 8.24(d, 2H), 8.05(d, 1H), 8.02-7.98(m, 2H) 7.96(t, 1H), 7.93(dd, 1H), 7.81(s, 1H), 7.72-7.68(m, 2H), 7.66-7.63(m, 1H), 7.61-7.58(m, 2H), 7.55-7.44(m, 8H), 2.72(s, 3H); EI, MS m/z(%): 499(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 8.81 (d, 1H), 8.74 (d, 1H), 8.24 (d, 2H), 8.05 (d, 1H), 8.02-7.98 (m, 2H) 1H), 7.96-7.58 (m, 2H), 7.55-7.68 (m, 2H) 7.44 (m, 8 H), 2.72 (s, 3 H); EI, MS m / z (%): 499 (100, M < + &
화합물 1-17 2-(3-(페난트렌-9-일)-5-(4-페닐나프탈렌-1-일)페닐)-1,10-페난트롤린의 합성Compound 1-17 Synthesis of 2- (3- (phenanthrene-9-yl) -5- (4-phenylnaphthalen-1-yl) phenyl) -1,10-phenanthroline
Figure PCTKR2017012707-appb-I000021
Figure PCTKR2017012707-appb-I000021
둥근 바닥 플라스크에 중간체 I(22 g, 44 mmole), 8-아미노퀴놀린-7-카르브알데히드(9.2 g, 53 mmole), 수산화칼륨(7.5 g, 133 mmol), 톨루엔 220 ml, 에탄올 11 ml를 넣고 5시간 동안 환류 교반시켰다. 반응 종료 후 과량의 메탄올로 석출하고 여과 건조하였다. 염화메틸렌으로 컬럼정제를 하고 재결정하여 화합물 1-16(수율 78%)을 수득하였다.(22 g, 44 mmole), 8-aminoquinoline-7-carbaldehyde (9.2 g, 53 mmole), potassium hydroxide (7.5 g, 133 mmol), toluene 220 ml and ethanol 11 ml were added to a round bottom flask And the mixture was refluxed for 5 hours. After completion of the reaction, the reaction mixture was precipitated with an excess amount of methanol, followed by filtration and drying. Column purification was carried out with methylene chloride and recrystallization was conducted to obtain Compound 1-16 (yield 78%).
1H NMR(300 MHz, CDCl3, ppm): δ 9.13(dd, 1H), 8.80(d, 1H), 8.75(d, 1H), 8.56(t, 1H), 8.52(t, 1H) 8.34(d, 1H), 8.25(dd, 1H), 8.20(d, 2H), 8.16(d, 1H), 7.98(dd, 1H), 7.94(d, 2H), 7.85(t, 1H), 7.81(dd, 2H), 7.71(d, 1H), 7.70-7.43(m, 13H); EI, MS m/z(%): 635(100, M+) 1 H NMR (300 MHz, CDCl 3, ppm): δ 9.13 (dd, 1H), 8.80 (d, 1H), 8.75 (d, 1H), 8.56 (t, 1H), 8.52 (t, 1H) 8.34 ( 1H), 7.85 (d, 2H), 7.85 (d, 1H), 8.25 (dd, , ≪ / RTI > 2H), 7.71 (d, 1H), 7.70-7.43 (m, 13H); EI, MS m / z (%): 635 (100, M < + &
유기발광소자의 제조Manufacture of organic light emitting device
유기발광소자에서 제2 전자수송층을 Li과 같은 알칼리 금속으로 도핑하여 제작하면 N-CGL 특성을 확인할 수 있다.The N-CGL characteristics can be confirmed by doping the second electron transporting layer with an alkali metal such as Li in the organic light emitting device.
1. 비교예의 제조예1. Production Example of Comparative Example
발광면적이 2 mm × 2 mm 크기가 되도록 ITO 기판을 패터닝한 후, 이소프로필 알코올과 UV 오존으로 각각 세정을 실시하였다. 이후, ITO기판을 진공 증착 장치의 기판 홀더에 장착하고 진공도가 1×10-7 torr가 되도록 압력을 잡았다.The ITO substrate was patterned to have a light emitting area of 2 mm x 2 mm, and then washed with isopropyl alcohol and UV ozone, respectively. Thereafter, the ITO substrate was mounted on a substrate holder of a vacuum deposition apparatus, and the pressure was adjusted so that the degree of vacuum was 1 x 10 < -7 > torr.
먼저, HAT-CN 화합물을 진공 증착하여 5 nm 두께로 형성하였다.이 화합물은 제1 정공주입층으로 작용한다.이 위에 제1 정공수송층으로 NPB 물질을 35 nm 두께로 형성하였다.First, a HAT-CN compound was vacuum deposited to form a 5 nm thick layer. This compound served as a first hole injection layer, and NPB material was formed thereon as a first hole transport layer to a thickness of 35 nm.
이후 CPB 물질을 호스트로, Ir 화합물을 도판트로 약 10% 질량비가 되도록 30 nm의 두께로 공증착하여 노란색 제1 발광층을 형성하였다. Thereafter, the CPB material was hosted and the Ir compound was co-deposited to a thickness of 30 nm so as to have a mass ratio of about 10% with a dopant to form a yellow first light emitting layer.
이 발광층위에 TmPyPB 화합물을 25 nm 두께로 제1 전자수송층을 형성하였다.이후 BPhen물질에 Li물질을 2% 질량비가 되도록 10 nm 두께로 공증착하여 N형 전하생성층을 형성하였다. 이후, P형 전하생성층으로 HAT-CN 화합물을 5 nm 두께로 진공 증착하였다. 이 물질은 제2 정공주입층으로도 활용된다. 이 위에 제2 정공수송층으로 NPB 물질을 35 nm 두께로 형성하였다.A TmPyPB compound was formed on the light emitting layer to a thickness of 25 nm to form a first electron transport layer. Then, an N-type charge generation layer was formed by co-depositing a Li material to a BPhen material to a thickness of 10 nm to a mass ratio of 2%. Then, a HAT-CN compound was vacuum deposited as a P-type charge generation layer to a thickness of 5 nm. This material also serves as a second hole injection layer. On this layer, NPB material was formed to a thickness of 35 nm as a second hole transporting layer.
이후 CPB 물질을 호스트로, Ir 화합물을 도판트로 약 10% 질량비가 되도록 30 nm의 두께로 공증착하여 노란색 제2 발광층을 형성하였다.이 발광층 위에 TmPyPB 화합물을 25 nm 두께로 제2 전자수송층을 형성하였다.이후 LiF 물질을 전자주입층으로 1 nm두께로 진공 증착하였다. 마지막으로 Al을 100 nm 두께로 증착시켜 음극을 형성하여 유기 EL 소자를 제작하였다.Then, a second yellow light emitting layer was formed by co-depositing a CPB material as a host and a 30 nm thick Ir compound as a dopant in a thickness of about 10% to form a second electron transporting layer having a thickness of 25 nm Then, a LiF material was vacuum deposited as an electron injection layer to a thickness of 1 nm. Lastly, Al was deposited to a thickness of 100 nm to form a cathode, thereby fabricating an organic EL device.
Figure PCTKR2017012707-appb-I000022
Figure PCTKR2017012707-appb-I000022
2. 실시예 1의 제조예2. Production Example of Example 1
위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층의 유기물질만 화합물 1-2로 바꾸어 유기발광소자를 제작하였다.Except that only the organic material of the N-type charge generation layer was replaced with the compound 1-2 to prepare an organic light emitting device.
3. 실시예 2의 제조예3. Production Example of Example 2
위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층의 유기물질만 화합물 1-13으로 바꾸어 유기발광소자를 제작하였다.Except that only the organic material of the N-type charge generation layer was changed to the compound 1-13 to prepare an organic light emitting device.
4. 실시예 3의 제조예4. Production Example of Example 3
위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층의 유기물질만 화합물 1-8로 바꾸어 유기발광소자를 제작하였다.Except that only the organic material of the N-type charge generation layer was replaced with the compound 1-8 to prepare an organic light emitting device.
5. 실시예 4의 제조예5. Production Example of Example 4
위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층의 유기물질만 화합물 1-17로 바꾸어 유기발광소자를 제작하였다.Except that only the organic material of the N-type charge generation layer was changed to the compound 1-17 to prepare an organic light emitting device.
이하에는 상기 실시예 1 내지 4 및 비교예 1의 유기발광소자의 전류 밀도, 구동전압, 전류 효율 및 외부양자효율을 측정하여 이하의 표 1에 나타내었다.The current density, the driving voltage, the current efficiency, and the external quantum efficiency of the organic light emitting devices of Examples 1 to 4 and Comparative Example 1 were measured and are shown in Table 1 below.
물질matter 구동전류J(mA/cm2)Driving current J (mA / cm 2 ) 구동전압(Voltage)The driving voltage 전류효율(cd/A)Current efficiency (cd / A) EQE(%)EQE (%)
비교예 1Comparative Example 1 BPhenBPhen 1010 9.49.4 107.8107.8 3535
실시예 1Example 1 1-21-2 1010 8.788.78 127.4127.4 40.740.7
실시예 2Example 2 1-131-13 1010 8.728.72 134.3134.3 43.143.1
실시예 3Example 3 1-81-8 1010 8.438.43 123.9123.9 40.340.3
실시예 4Example 4 1-171-17 1010 8.008.00 122.5122.5 40.740.7
실시예 1 내지 4의 구동전압과 전류 효율 등이 비교예 1과 비교하여 향상된 것을 알 수 있다.It can be seen that the driving voltage and the current efficiency of Examples 1 to 4 are improved as compared with Comparative Example 1.
본 발명은 반드시 이러한 실시예로 국한되는 것은 아니고, 본 발명의 기술사상을 벗어나지 않는 범위 내에서 다양하게 변형 실시될 수 있다. 따라서, 본 발명에 개시된 실시예들은 본 발명의 기술 사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 그러므로, 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 본 발명의 보호 범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.The present invention is not necessarily limited to these embodiments, and various modifications may be made without departing from the technical idea of the present invention. Therefore, the embodiments disclosed in the present invention are intended to illustrate rather than limit the scope of the present invention, and the scope of the technical idea of the present invention is not limited by these embodiments. Therefore, it should be understood that the above-described embodiments are illustrative in all aspects and not restrictive. The scope of protection of the present invention should be construed according to the following claims, and all technical ideas within the scope of equivalents should be construed as falling within the scope of the present invention.

Claims (9)

  1. 하기 화학식 1로 표시되는 페난트롤린 화합물:A phenanthroline compound represented by the following formula (1)
    [화학식 1][Chemical Formula 1]
    Figure PCTKR2017012707-appb-I000023
    Figure PCTKR2017012707-appb-I000023
    상기 화학식 1에서,In Formula 1,
    R1은 치환 또는 치환되지 않는 탄소수 3 내지 60의 아릴기, 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 치환 혹은 치환되지 않은 5원 내지 60원 헤테로아릴기, 아릴아민기 및 2차 아민기로 구성된 군으로부터 선택된다.R 1 is a substituted or unsubstituted aryl group having 3 to 60 carbon atoms, a substituted or unsubstituted 5 to 60 membered heteroaryl group containing at least one hetero atom selected from nitrogen, oxygen and sulfur, an arylamine group and 2 / RTI > amine group.
  2. 제1항에 있어서, 상기 화학식 1로 표시되는 화합물은 하기 표시되는 화합물로 이루어진 군으로부터 선택되는 것을 특징으로 하는 페난트롤린 화합물:The phenanthroline compound according to claim 1, wherein the compound represented by the formula (1) is selected from the group consisting of the following compounds:
    Figure PCTKR2017012707-appb-I000024
    Figure PCTKR2017012707-appb-I000024
    Figure PCTKR2017012707-appb-I000025
    Figure PCTKR2017012707-appb-I000025
  3. 제1전극, The first electrode,
    제2전극, 및 A second electrode, and
    상기 제1전극과 제2전극 사이에 위치하는 1층 이상의 유기물층을 포함하며,And one or more organic layers disposed between the first electrode and the second electrode,
    상기 유기물층 중 1층 이상은 제1항 또는 제2항에 따른 페난트롤린 화합물을 포함하는 유기발광소자.Wherein at least one of the organic material layers comprises the phenanthroline compound according to any one of claims 1 to 3.
  4. 제3항에 있어서, 상기 유기물층은 발광층, 정공주입층, 정공수송층, 및 정공주입 및 정공수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함하는 것을 특징으로 하는 유기발광소자.The organic light emitting device according to claim 3, wherein the organic material layer comprises at least one layer selected from the group consisting of a light emitting layer, a hole injecting layer, a hole transporting layer, and a layer simultaneously injecting holes and transporting holes.
  5. 제3항에 있어서, 상기 유기물층은 발광층, 전자주입층, 전자수송층, 및 전자주입 및 전자수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함하는 것을 특징으로 하는 유기발광소자.The organic light emitting device according to claim 3, wherein the organic material layer includes at least one layer selected from the group consisting of a light emitting layer, an electron injecting layer, an electron transporting layer, and a layer simultaneously performing electron injection and electron transporting.
  6. 제3항에 있어서, 상기 유기물층은 적어도 하나의 전하생성층(Charge Generation Layer: CGL)을 포함하는 것을 특징으로 하는 유기발광소자.The organic light emitting diode according to claim 3, wherein the organic layer includes at least one charge generation layer (CGL).
  7. 제3항에 있어서, 상기 전하생성층은 n형인 것을 특징으로 하는 유기발광 소자.The organic light emitting device according to claim 3, wherein the charge generating layer is n-type.
  8. 제1전극;A first electrode;
    제2전극; 및A second electrode; And
    상기 제1전극과 상기 제2전극 사이에 위치하며 제1발광층을 포함하는 제1발광부;A first light emitting portion located between the first electrode and the second electrode and including a first light emitting layer;
    상기 제2전극과 상기 제1발광부 사이에 위치하며 제2발광층을 포함하는 제2발광부;A second light emitting portion located between the second electrode and the first light emitting portion and including a second light emitting layer;
    상기 제1발광부와 상기 제2발광부 사이에 위치하는 제1전하생성층을 포함하며,And a first charge generation layer disposed between the first light emitting portion and the second light emitting portion,
    상기 제1발광부, 제2발광부 및 제1전하생성층 중 적어도 하나의 층은 제1항 또는 제2항에 따른 페난트롤린 화합물을 포함하는 유기발광소자.Wherein at least one of the first light emitting portion, the second light emitting portion, and the first charge generating layer comprises the phenanthroline compound according to any one of Claims 1 to 4.
  9. 제8항에 있어서,9. The method of claim 8,
    상기 제2전극과 상기 제2발광부 사이에 위치하며 제3발광층을 포함하는 제3발광부; 및A third light emitting portion positioned between the second electrode and the second light emitting portion and including a third light emitting layer; And
    상기 제2발광부와 상기 제3발광부 사이에 위치하는 제2전하생성층을 더 포함하며,And a second charge generation layer disposed between the second light emitting portion and the third light emitting portion,
    상기 제3발광부 및 제2전하생성층 중 적어도 하나의 층은 제1항 또는 제2항에 따른 페난트롤린 화합물을 포함하는 것을 특징으로 하는 유기발광소자.Wherein at least one of the third light emitting portion and the second charge generating layer comprises the phenanthroline compound according to any one of Claims 1 to 3.
PCT/KR2017/012707 2017-11-09 2017-11-10 Phenanthroline compound and organic light emitting device comprising same WO2019093545A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2017-0148709 2017-11-09
KR1020170148709A KR101984677B1 (en) 2017-11-09 2017-11-09 phenanthroline compound and organic light emitting element comprising the same

Publications (1)

Publication Number Publication Date
WO2019093545A1 true WO2019093545A1 (en) 2019-05-16

Family

ID=66439273

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/012707 WO2019093545A1 (en) 2017-11-09 2017-11-10 Phenanthroline compound and organic light emitting device comprising same

Country Status (2)

Country Link
KR (1) KR101984677B1 (en)
WO (1) WO2019093545A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210069785A (en) 2019-12-03 2021-06-14 삼성디스플레이 주식회사 Organic compound containing heterocyclic ring and having low lumo properties, and organic electroluminescent device using the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090103318A (en) * 2008-03-28 2009-10-01 (주)그라쎌 Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20110119206A (en) * 2010-04-27 2011-11-02 다우어드밴스드디스플레이머티리얼 유한회사 Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20140056245A (en) * 2008-03-19 2014-05-09 이데미쓰 고산 가부시키가이샤 Anthracene derivatives, luminescent materials and organic electroluminescent devices
KR20150113754A (en) * 2014-03-31 2015-10-08 엘지디스플레이 주식회사 Carbazole compound and organic light emitting diode including the same
KR20170116500A (en) * 2016-04-11 2017-10-19 주식회사 두산 Organic light-emitting compound and organic electroluminescent device using the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140056245A (en) * 2008-03-19 2014-05-09 이데미쓰 고산 가부시키가이샤 Anthracene derivatives, luminescent materials and organic electroluminescent devices
KR20090103318A (en) * 2008-03-28 2009-10-01 (주)그라쎌 Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20110119206A (en) * 2010-04-27 2011-11-02 다우어드밴스드디스플레이머티리얼 유한회사 Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20150113754A (en) * 2014-03-31 2015-10-08 엘지디스플레이 주식회사 Carbazole compound and organic light emitting diode including the same
KR20170116500A (en) * 2016-04-11 2017-10-19 주식회사 두산 Organic light-emitting compound and organic electroluminescent device using the same

Also Published As

Publication number Publication date
KR101984677B1 (en) 2019-05-31
KR20190052882A (en) 2019-05-17

Similar Documents

Publication Publication Date Title
WO2010131855A2 (en) Compound containing a 5-membered heterocycle and organic light-emitting diode using same, and terminal for same
WO2014142472A1 (en) Compound for organic electrical element, organic electrical element using same, and electronic device thereof
WO2012173370A2 (en) Novel compounds and organic electronic device using same
WO2010114267A2 (en) Organic electronic device, compounds for same, and terminal
WO2013036044A2 (en) Material for organic light-emitting device, and organic light-emitting device using same
WO2010071362A2 (en) Deuterated anthracene derivative, and organic light-emitting device comprising same
WO2010076986A4 (en) Novel compounds for an organic photoelectric device, and organic photoelectric device comprising same
WO2014142467A1 (en) Compound for organic electronic element, organic electronic element using compound, and electronic device comprising organic electronic element
WO2011155742A2 (en) Compound comprising carbazole and aromatic amine derivatives, organic electronic element using same, and terminal comprising the organic electronic element
WO2011081431A2 (en) Organic light emitting compound, and organic electroluminescent device using same
WO2014129869A1 (en) Organic field effect light-emitting device
WO2011126225A1 (en) Novel compounds for organic electronic material and organic electroluminescent device using the same
WO2019093544A1 (en) Phenanthroline compound and organic light emitting device comprising same
WO2015009102A1 (en) Organic light emitting compound and organic electroluminescent element using same
WO2017142310A1 (en) Heterocyclic compound and organic electroluminescent device comprising same
WO2011136482A1 (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
WO2011149284A2 (en) Hetero-atom-containing compound in which carbazole and fluorene are fused, an organic electrical element using the same and a terminal thereof
WO2014092431A1 (en) Novel compound, and organic electroluminescent device comprising same
WO2021071345A2 (en) Polycyclic compound and organoelectro luminescent device using same
WO2020218648A1 (en) Phenanthroline compound and organic light-emitting device comprising same
WO2010047551A2 (en) Aromatic derivatives and organic electroluminescent device comprising the same
WO2012093862A2 (en) Phenazine-based compound and organic electroluminescent device including same
WO2010085087A2 (en) Novel cycloalkene derivatives and organic electronic devices using the same
WO2020175779A1 (en) Novel compound and organic light emitting device using same
WO2019093545A1 (en) Phenanthroline compound and organic light emitting device comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17931665

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17931665

Country of ref document: EP

Kind code of ref document: A1